Cash · 2011–2025
Ani Pharmaceuticals cash
$286M+97.1% · FY2025
Ani Pharmaceuticals (ANIP) reported $286M in cash for fiscal 2025, +97.1% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $286M | +97.1% | Open → |
| FY20242024-12-31 | $145M | −34.5% | Open → |
| FY20232023-12-31 | $221M | +358.5% | Open → |
| FY20222022-12-31 | $48.2M | −51.9% | Open → |
| FY20212021-12-31 | $100M | +1,175.4% | Open → |
| FY20202020-12-31 | $7.9M | −87.4% | Open → |
| FY20192019-12-31 | $62.3M | +44.9% | Open → |
| FY20182018-12-31 | $43.0M | +38.1% | Open → |
| FY20172017-12-31 | $31.1M | +13.8% | Open → |
| FY20162016-12-31 | $27.4M | −82.3% | Open → |
| FY20152015-12-31 | $155M | −8.5% | Open → |
| FY20142014-12-31 | $169M | +1,422.2% | Open → |
| FY20132013-12-31 | $11.1M | +100,854.5% | Open → |
| FY20122012-12-31 | $11,000 | +$11,000 | Open → |
| FY20112011-12-31 | $0 | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ani Pharmaceuticals cash |url=https://companiesranked.com/en/company/ani-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ani Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/ani-pharmaceuticals/cash-on-handBibTeX
@misc{companiesranked-en-company-ani-pharmaceuticals-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Ani Pharmaceuticals cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ani-pharmaceuticals/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001023024-26-000069 · August 7, 2026
{{cite web |title=Ani Pharmaceuticals cash — 10-Q (0001023024-26-000069) |url=https://www.sec.gov/Archives/edgar/data/1023024/000102302426000069/anip-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-07}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.